| Ticker Details |
|
Instil Bio, Inc.
|
| IPO Date: |
March 19, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$51.41M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.68 | 4.36%
|
| Avg Daily Range (30 D): |
$0.13 | 1.79%
|
| Avg Daily Range (90 D): |
$0.13 | 1.69%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.31M |
| Avg Daily Volume (30 D): |
.01M |
| Avg Daily Volume (90 D): |
.02M |
| Trade Size |
| Avg Trade Size (Sh.): |
116 |
| Avg Trade Size (Sh.) (30 D): |
83 |
| Avg Trade Size (Sh.) (90 D): |
93 |
| Institutional Trades |
| Total Institutional Trades: |
192 |
| Avg Institutional Trade: |
$2.21M |
| Avg Institutional Trade (30 D): |
$1.01M |
| Avg Institutional Trade (90 D): |
$1.01M |
| Avg Institutional Trade Volume: |
.02M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.85M |
| Avg Closing Trade (30 D): |
$.58M |
| Avg Closing Trade (90 D): |
$.58M |
| Avg Closing Volume: |
36.19K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$-4.43
|
$-.63
|
$-.62
|
|
Diluted EPS
|
$-4.43
|
$-.63
|
$-.62
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-30.28M
|
$-4.3M
|
$-4.2M
|
|
Operating Income / Loss
|
$-37.17M
|
$-5.58M
|
$-7.01M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-1.03M
|
$M
|
$.01M
|
|
PE Ratio
|
|
|
|
|
|
|
